Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cisplatin (platinol) (1 trial)
docetaxel (taxotere) (1 trial)
immuvac (2 trials)
paclitaxel (taxol) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Mycobacterium Infections (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (4 total)